General
Preferred name
LEVONANTRADOL
Synonyms
LEVONANTRADOL HYDROCHLORIDE ()
CP-50556-1 ()
NSC-331615 ()
CP-50,556-1 ()
Levonantradol hcl ()
P&D ID
PD164360
CAS
71048-87-8
70222-86-5
Tags
available
drug candidate
Drug indication
Analgesic
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Levonantradol is a synthetic cannabinoid analogue .
(GtoPdb)
DESCRIPTION
Levonantrado is a synthetic cannabinoid analog of dronabinol developed by Pfizer in the 1980s. Levonantrado is around 30x more potent than THC, and exhibits antiemetic and analgesic effects via activation of CB1 and CB2cannabinoid receptors. Now, Levonantradol is not used in medicine,but it is widely used in research into the potential therapeutic applications of cannabinoids.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
3
BOC Sciences Bioactive Compounds
ChEMBL Drugs
Guide to Pharmacology
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
19
Molecular Weight
437.26
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
7
Ring Count
4
Aromatic Ring Count
2
cLogP
5.46
TPSA
67.79
Fraction CSP3
0.52
Chiral centers
5.0
Largest ring
6.0
QED
0.44
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Solubility
Soluble in DMSO
Source data
